SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns upcoming quarterly results are the dominant focus, with traders watching guidance on AI-driven HBM and DRAM demand, pricing, margins, and how long the memory upcycle can last. Many expect a strong report, but others argue that optimism is already priced in and that a less-convincing outlook could prompt a sell-the-news reaction.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins sharp slide toward 52-week lows has traders focused on analyst concerns that growth in its AXON/MAX ad platform may be stalling and that Unity competition could pressure market share, alongside the companies data-collection dispute. Bulls argue e-commerce adoption and pixel-install data remain encouraging and view the selloff as overdone; bears see signs of decelerating growth and continued downside risk.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data showing slower upper-limb deterioration in Duchenne patients treated with deramiocel has lifted attention ahead of the FDA decision. Bullish traders see the findings as strengthening the treatments case, while skeptics question whether open-label results address the FDAs prior concerns; short-squeeze talk is prominent but speculative.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

A Delaware court ruled that two United Therapeutics patent claims covering YUTREPIA use in PH-ILD are valid and infringed, triggering a sharp selloff and trading halts as traders weigh the uncertain remedies and Liquidias planned appeal. The community is split between viewing the ruling as a potentially serious threat to the drugs availability and calling the reaction an overreaction, with many expressing alarm over losses.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Rising long-term Treasury yields and expectations of persistently high rates are weighing on TLT, with traders also pointing to inflation, oil and government-debt concerns. The conversation is largely bearish on further bond-price declines, though some traders see oversold conditions as a potential buying opportunity.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to place VantageScore alongside FICO on Fannie Mae and Freddie Mac mortgage pricing grids, alongside Rocket Mortgages planned use of VantageScore, has raised concerns that FICO could lose mortgage-market share and pricing power, driving a sharp selloff. Traders are divided between expecting further declines as the companys competitive moat is reassessed and viewing the drop as an oversold buying opportunity given FICOs continued role in lending.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned Q4 2026 BLA submission for CAN-2409 in localized prostate cancer is the main focus, alongside discussion of encouraging Phase 3 and immune-biomarker data. Traders are divided over whether shedding-study and manufacturing validation work will keep the filing on schedule, with bullish confidence in the data countered by concerns about delays, cash burn, and dilution.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Fords prolonged decline and test of long-term support dominate discussion, with traders split between buying an oversold bounce and expecting further weakness ahead of earnings. Concerns include F-150 production and supplier disruptions that are expected to weigh on wholesale results, alongside broader worries about sales and trade risks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas new credit facilities are dominating discussion, with traders split between viewing them as financial flexibility for AI, robotics and other capital spending plans and seeing them as a sign of funding pressure and added debt risk. The debate is set against bearish sentiment around the stocks recent weakness, while some traders see the financing as supporting Teslas longer-term expansion.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhoods summit rollout of AI trading agents, crypto perpetual futures, expanded-hours stock trading, and earnings-linked prediction contracts is driving attention. Traders are debating the sharp reversal after an initial premarket rally, with many calling it a sell-the-news reaction and criticizing the presentation, while others see the new products as a bullish expansion of the platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


BiTS_MAXXII

Jesse Pinkman